Skip to main content
. Author manuscript; available in PMC: 2015 Feb 4.
Published in final edited form as: Sci Transl Med. 2012 Oct 10;4(155):155ra138. doi: 10.1126/scitranslmed.3004414

Fig. 4.

Fig. 4

ELISpot responses to each vaccine antigen present at all doses. (A) Overall background-subtracted cellular immune responses against four vaccine antigens. (B to E) Background-subtracted antigen-specific cellular immune responses in the 0.3, 1.0, and 3.0 mg groups to (B) HPV16 E6, (C) HPV16 E7, (D) HPV18 E6, and (E) HPV18 E7.